Analyst Coverage
Roth Capital Partners
IMU: Sells CGMP Facility That Manufactures Azer-cel, MAST Trial Making Progress
Roth Capital Partners
Clinical Progress With onCARlytics And VAXINIA In Solid Tumors
Diamond Equity Research
Q2 FY2024 Clinical Milestones, Collaborations, and Financial Results Update
Diamond Equity Research
VAXINIA’s Releases Early Positive Data, PD1-Vaxx and Azer-cel Advancing Through Clinical Pipeline
Roth Capital Partners